Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01014195 · ClinicalTrials.gov registry record

Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
237
Enrollment target

NCT01014195: Completed study, sponsored by St. Jude Children's Research Hospital.

NCT01014195 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 237 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01014195 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
237 participants
Enrollment target

Study Summary

1. This study will evaluate the association between changes in basic cognitive and behavioral functioning by the end of chemotherapy treatment, and the later development of higher order executive functions in pediatric acute lymphoblastic leukemia (ALL). 2. The association between acute treatment-related changes in brain integrity and subsequent brain maturation in long-term survivors of pediatric ALL will be evaluated. 3. The association between patterns of behavioral and executive dysfunction and brain maturation in long-term survivors of pediatric ALL will be examined. 4. The association between genetic polymorphisms in key enzyme pathways and higher order brain development in long-term survivors of pediatric ALL will be explored. 5. The associations between biologic and behavioral indices of fatigue/sleep and higher order brain development in long-term survivors of pediatric ALL will be explored.

Interventions

  • OTHER Neurocognitive and behavioral evaluation

Trial Details

FieldValue
Enrollment Target 237 participants
Start Date 2010-01
Est. Completion 2014-10

What the finished NCT01014195 record still lists

NCT01014195 is an observational study that tracks outcomes without assigning an intervention. The registered 237 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Neurocognitive and behavioral evaluation is the first listed.

NCT01014195 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01014195 about?

NCT01014195 is a clinical study titled "Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors". 1. This study will evaluate the association between changes in basic cognitive and behavioral functioning by the end of chemotherapy treatment, and the later development of higher order executive functions in pediatric acute lymphoblastic leukemia (ALL). 2. The association between acute treatment-re...

What is the current status of trial NCT01014195?

This trial is currently completed. The enrollment target is 237 participants. The study started on 2010-01. Estimated completion is 2014-10.

What interventions are being tested in trial NCT01014195?

The interventions under investigation include: Neurocognitive and behavioral evaluation (OTHER).

Who is sponsoring clinical trial NCT01014195?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05974176 · 237 participants · NA

    Considering Racial and Acculturation Stress in Addressing Trauma

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT05400252 · 238 participants · NA

    Whole Health in VA Mental Health: Omnis Salutis

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01014195, the US trial registry maintained by the National Library of Medicine. NCT01014195 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.